Table 1 Patient characteristics
| Â | All patients | Patients with mitochondria samples | ||
|---|---|---|---|---|
Control (n = 16) | RIPC n = 13) | Control (n = 14) | RIPC (n = 10) | |
Age | 66 ± 9.6 | 70 ± 7.5 | 67 ± 9.7 | 71 ± 7.3 |
Body mass index | 27.5 ± 4.1 | 25.6 ± 2.9 | 26.9 ± 3.6 | 25.5 ± 2.6 |
Euroscore, mean | 3.1 ± 1.9 | 3.8 ± 2.0 | 3.1 ± 1.4 | 3.8 ± 2.1 |
Angina pectoris | 15 (94) | 10 (77) | 13 (93) | 9 (90) |
 Grade 1 | 0 (0) | 1 (8) | 0 (0) | 1 (10) |
 Grade 2 | 5 (31) | 4 (31) | 5 (36) | 4 (40) |
 Grade 3 | 6 (38) | 4 (31) | 6 (43) | 3 (30) |
 unknown | 4 (25) | 1 (8) | 2 (14) | 1 (10) |
Previous myocardial infarction | 7 (44) | 8 (62) | 5 (36) | 6 (60) |
Previous PCI | 2 (13) | 5 (39) | 2 (14) | 4 (40) |
Hypertension | 11 (69) | 8 (62) | 9 (64) | 5 (50) |
Hypercholesterolaemia | 7 (44) | 4 (31) | 6 (43) | 4 (40) |
Ever smoked | 11 (69) | 9 (69) | 11 (79) | 7 (70) |
Pack-year, mean (SD) | 29 ± 14 | 34 ± 19 | 29 ± 14 | 39 ± 15 |
Family history IHD | 6 (38) | 6 (46) | 6 (43) | 4 (40) |
COPD | 2 (13) | 1 (8) | 2 (13) | 1 (10) |
Peripheral vascular disease | 1 (6) | 1 (8) | 1 (7) | 0 (0) |
Cerebrovascular accident | 0 (0) | 1 (8) | 0 (0) | 1 (10) |
Medication | ||||
 Statins | 16 (100) | 13 (100) | 14 (100) | 10 (100) |
 β-blocker | 13 (81) | 11 (85) | 11 (79) | 8 (80) |
 ACE inhibitor | 7 (44) | 4 (31) | 6 (43) | 4 (40) |
 Diuretics | 4 (25) | 1 (8) | 4 (29) | 1 (10) |
 Nitrate | 7 (44) | 5 (39) | 6 (43) | 4 (40) |
 Coumarin derivatives | 1 (6) | 0 (0) | 1 (7) | 0 (0) |
 Clopidogrel | 2 (13) | 5 (39) | 0 (0) | 4 (40) |
 Carbasalate calcium/aspirin | 16 (100) | 11 (85) | 14 (100) | 9 (90) |